Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VASST: V10153 in acute ischaemic stroke
NCT00144014Phase 2Completed
- Sponsor
- Vernalis
- Start
- Aug 2005
- Primary completion
- Nov 2008
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of troplasminogen alfa in ischemic stroke, sponsored by Vernalis. Started Aug 2005; status: completed.
02
Drugs
troplasminogen alfa
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT00144014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00144014.